NSE Approves Listing of Vaishali Pharma's Preferential Equity Shares
Vaishali Pharma Ltd · Others (Uncategorized) · 17 Oct 2026, 9:52 pm
NSE Approves Listing of Vaishali Pharma's Preferential Equity Shares Vaishali Pharma Limited received approval from the National Stock Exchange of India for the listing and trading of 4,537,865 equity shares of face value ₹2 each, allotted on a preferential basis. The shares were admitted to dealings effective 16th Oct'26 under the symbol VAISHALI (Series: EQ). The newly issued securities bear distinctive numbers ranging from 130462131 to 134999995 and remain subject to a statutory lock-in period ending on 30th Apr'27.
Original exchange filing (PDF)
More announcements from Vaishali Pharma Ltd
- Vaishali Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 15 Nov 2026
- Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 14 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Non- Executive Independent Director of the company w.e.f. November 05, 2026. · 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. · 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising. · 03 Nov 2026
- To consider Fund Raising and other business matters · 03 Nov 2026
